Rocket Lab's stock has surged 356.85% over the past year, fueled by its first $200 million revenue quarter and a record $2.2 billion backlog. Despite strong growth and bullish forecasts tied to its upcoming Neutron rocket and Golden Dome contracts, the stock trades above fundamentals with a current price of $122.39 versus a $113.26 price target, implying a 7.46% downside. Analysts remain divided, with some optimistic about future contracts and launches, while concerns persist over high valuation, net losses, and dilution from recent capital raises. The company’s near-term outlook includes Q2 revenue guidance of $225-$240 million and a potential Neutron debut in late 2026, which could significantly impact its valuation trajectory.
On December 1, 2025, YieldMax Ultra Option Income Strategy ETF (ULTY) executed a 1-for-10 reverse split, raising its share price tenfold but not increasing investor value. The fund charges a high 1.24% expense ratio, significantly more than comparabl...
YieldMax Ultra Option Income Strategy ETF (ULTY) promises a high annualized yield near 62% through weekly distributions by selling options on volatile tech stocks. However, its total return over the past year was -4.8%, far below the S&P 500's 22% ga...
